| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the ICRF Cancer Medicine Research Unit*
and
Departments of Pathology
and
Cytogenetics,
St. James's University
Hospital, Leeds, United Kingdom
cDNA sequences for human uroplakins UPIa, UPIb, UPII, and UPIII were cloned and used to investigate uroplakin transcription by normal and neoplastic urothelial cells. Normal urothelium expressed mRNA for all four uroplakins, although UPIII could be detected only by ribonuclease protection assay. By in situ hybridization, UPIa and UPII were confined to superficial cells and UPIb was also expressed by intermediate cells. Cultured normal human urothelial cells showed a proliferative basal/intermediate cell phenotype and constitutive expression of UPIb only. Uroplakin expression by transitional cell carcinoma cell lines was related to their differentiated phenotype in vitro. RT4 cells expressed all uroplakins, VM-CUB-3 expressed three uroplakins, RT112 and HT1376 cells expressed only UPIb in high abundance, and COLO232, KK47, and EJ cells had no detectable expression. These results correlated with patterns of uroplakin expression in tumors. UPIa and UPII were detected superficially only in well differentiated transitional cell carcinoma papillae. UPIb was positive in seven of nine and overexpressed in five of nine noninvasive transitional cell carcinomas and was also present in four of eight invasive transitional cell carcinomas. Lymph node metastases retained the same pattern of UPIb expression as the primary tumor. Unlike the three differentiation-regulated uroplakins, UPIb may have an alternative role in urothelial cell/tissue processes.
This article has been cited by other articles:
 |
|
 |
|
  T.-T. Sun Altered phenotype of cultured urothelial and other stratified epithelial cells: implications for wound healing Am J Physiol Renal Physiol, July 1, 2006; 291(1): F9 - F21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Cross, I. Eardley, H. J. Leese, and J. Southgate A biomimetic tissue from cultured normal human urothelial cells: analysis of physiological function Am J Physiol Renal Physiol, August 1, 2005; 289(2): F459 - F468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Koh and A. Atala Tissue Engineering, Stem Cells, and Cloning: Opportunities for Regenerative Medicine J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1113 - 1125. [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Varley, J. Stahlschmidt, B. Smith, M. Stower, and J. Southgate Activation of Peroxisome Proliferator-Activated Receptor-{gamma} Reverses Squamous Metaplasia and Induces Transitional Differentiation in Normal Human Urothelial Cells Am. J. Pathol., May 1, 2004; 164(5): 1789 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Varley, J. Stahlschmidt, W.-C. Lee, J. Holder, C. Diggle, P. J. Selby, L. K. Trejdosiewicz, and J. Southgate Role of PPAR {gamma} and EGFR signalling in the urothelial terminal differentiation programme J. Cell Sci., April 15, 2004; 117(10): 2029 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P.T. Higgins, L. Wang, N. Kambham, K. Montgomery, V. Mason, S. U. Vogelmann, K. V. Lemley, P. O. Brown, J. D. Brooks, and M. van de Rijn Gene Expression in the Normal Adult Human Kidney Assessed by Complementary DNA Microarray Mol. Biol. Cell, February 1, 2004; 15(2): 649 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Koga, S. Kawakami, Y. Fujii, K. Saito, Y. Ohtsuka, A. Iwai, N. Ando, T. Takizawa, Y. Kageyama, and K. Kihara Impaired p63 Expression Associates with Poor Prognosis and Uroplakin III Expression in Invasive Urothelial Carcinoma of the Bladder Clin. Cancer Res., November 15, 2003; 9(15): 5501 - 5507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Bugajska, N. T. Georgopoulos, J. Southgate, P. W. M. Johnson, P. Graber, J. Gordon, P. J. Selby, and L. K. Trejdosiewicz The Effects of Malignant Transformation on Susceptibility of Human Urothelial Cells to CD40-Mediated Apoptosis J Natl Cancer Inst, September 18, 2002; 94(18): 1381 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, N. Ramesh, Y. Chen, Y. Li, J. Dilley, P. Working, and D.-C. Yu Identification of Human Uroplakin II Promoter and Its Use in the Construction of CG8840, a Urothelium-specific Adenovirus Variant That Eliminates Established Bladder Tumors in Combination with Docetaxel Cancer Res., July 1, 2002; 62(13): 3743 - 3750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Seraj, A. R. Thomas, J. L. Chin, and D. Theodorescu Molecular Determination of Perivesical and Lymph Node Metastasis after Radical Cystectomy for Urothelial Carcinoma of the Bladder Clin. Cancer Res., June 1, 2001; 7(6): 1516 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Smith, W. J. Kennedy, P. Harnden, P. J. Selby, L. K. Trejdosiewicz, and J. Southgate Identification of Genes Involved in Human Urothelial Cell-Matrix Interactions: Implications for the Progression Pathways of Malignant Urothelium Cancer Res., February 1, 2001; 61(4): 1678 - 1685. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Adachi, K. Okubo, and S. Kinoshita Human Uroplakin Ib in Ocular Surface Epithelium Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 2900 - 2905. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
